Delivery Order SPE2DB20D2002-SPE2DB25FL70J
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of 1,000 units of Duloxetine HCL DR 60 mg capsules, valued at $1,046.72. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $1,919.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of 1,000 capsules of Duloxetine HCL DR 20 mg. This non-set-aside contract, which is due for completion by August 13, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $3,022.92 for 1,000 capsules of Duloxetine HCL DR 60 mg. The award, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, carries a firm fixed price and was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,434.93 to AmerisourceBergen Drug Corp for 1,000 units of Duloxetine HCL DR 60 mg capsules, with an ultimate completion date of August 20, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency Troop Support Medical awarded a $135,870 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90,000 capsules of 30mg duloxetine hydrochloride. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by August 28, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite-delivery/indefinite-quantity contract...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 60 mg capsules (90-count) with a ceiling value of $2,267.82. The contract was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-set-aside, competitively awarded delivery order under firm fixed pricing. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a $1,548.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562086980 Duloxetine HCl DR 40 MG capsules. Under this contract, Amerisourcebergen will deliver 30 units of the specified generic pharmaceutical to a location in Conshohocken, Pennsylvania by September 8, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with any broader indefinite...
- The Defense Logistics Agency awarded a $97,630 delivery order to AmerisourceBergen Drug Corporation for 1,000 capsules of 60mg duloxetine hydrochloride. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania over a three-day period concluding on August 14, 2023. The firm fixed price contract has...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,075.68 firm-fixed-price delivery order is for the supply of 4567655738 - Duloxetine HCL DR 40 MG Capsules, 30s. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,025.40 firm fixed-price delivery order is for the supply of 4,564,377,705 units of Duloxetine HCL DR 40 mg capsules. The contract has an ultimate completion date of April 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL70JDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of 1,000 units of Duloxetine HCL DR 60 mg capsules at a ceiling value of $1,433.94. This is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania that serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive capabilities in supplying a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for Duloxetine—a neurological medication commonly used to treat depression and anxiety disorders—reflects the company's role in supporting military medical supply chain requirements through competitive, firm fixed-price transactions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/25/25 |